PDLIM7 and Burkitt lymphoma: Application of the most widespread BET BRDi inhibitor, JQ1 (Filippakopoulos et al., 2010), to EBV-infected Burkitt lymphoma (BL) cell lines caused a decrease in transcription from the C promoter (Cp) (a necessary process in cellular immortalization) but, interestingly, not the LMP1 promoter (Palermo et al., 2011).